Nephronette Profile Banner
Abinet Aklilu Profile
Abinet Aklilu

@Nephronette

Followers
381
Following
2K
Media
7
Statuses
202

MD, MPH. Kidney 🫘doctor @YaleIMed #CTRA || ⚖️🌍access to kidney care, kidney disease progression prevention, clinical trials. 🇪🇹🇺🇲

Connecticut, USA
Joined March 2011
Don't wanna be here? Send us removal request.
@Nephronette
Abinet Aklilu
27 days
Incredibly humbled and honored to receive this award in honor of the inspiring physician scientist Iva Dostanic & for the opportunity to share our prelim data & ongoing RCT of SGLT2i in acute CRS. I'm so grateful to my mentor @fperrywilson, patients, AHA @YaleNephrology @YaleIMed.
@YaleNephrology
Yale Nephrology
27 days
Congratulations to Dr. Abinet Aklilu (@Nephronette) on being awarded the 2025 Iva Dostanic Physician-Scientist Trainee Award!! We are all so proud!! . @fperrywilson @brewster_ursula @dmoledina @YaleIMed
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
3
32
@Nephronette
Abinet Aklilu
1 month
RT @graekan: It was a humbling return 14yrs later. I am blessed to have you @brewster_ursula & @fperrywilson as mentors. And @Nephronette….
0
14
0
@Nephronette
Abinet Aklilu
6 months
RT @ASNKidney360: Hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for patients with hematologic malignanci….
0
4
0
@Nephronette
Abinet Aklilu
8 months
RT @ASNKidney360: Although tuberculosis (TB) is associated with significant mortality and morbidity, its impact on kidney function is not w….
0
18
0
@Nephronette
Abinet Aklilu
9 months
RT @rkalyes1: 🔥 ✨ Enjoy our study on Incidence of Acute Kidney Injury and Associated Mortality among Individuals with Drug-Susceptible Tube….
0
24
0
@Nephronette
Abinet Aklilu
9 months
RT @anushreeshirali: K360 series on Update in Onco-Nephrology continues in this issue, with @mbigottevieira and @nymurakami discussing canc….
0
6
0
@Nephronette
Abinet Aklilu
9 months
RT @YaleNephrology: Congratulations to current Yale faculty @GolestanehLadan and former Yale faculty @ndahl48 on receiving the Distinguishe….
0
2
0
@Nephronette
Abinet Aklilu
9 months
RT @YaleNephrology: 📸 @meganlebaker giving her first oral presentation at @ASNKidney #KidneyWk this afternoon, on her work characterizing i….
0
7
0
@Nephronette
Abinet Aklilu
9 months
RT @fperrywilson: Here we go, #kidneywk! @Nephronette presenting the results of the Kidney Action Team Randomized Trial at the High-Impact….
0
3
0
@Nephronette
Abinet Aklilu
9 months
Check out our manuscript now out on JAMA doi:10.1001/jama.2024.22718 and 👉Yale News article
Tweet media one
Tweet media two
1
2
6
@Nephronette
Abinet Aklilu
9 months
Thanks to the ASN for selecting our trial of Early personalized recommendations for AKI for presentation at the High-Impact Clinical Trials session. Many thanks to my wonderful mentor @fperrywilson and all KAT physician and pharmacist volunteers! #kidneyweek2024 #KidneyWk.
@YaleNephrology
Yale Nephrology
9 months
📸‼️@Nephronette presenting the results of Kidney Action Team Randomized Trial at the High-Impact Clinical Trials session!! . Would rapid, personalized recs within 1 hr of AKI from a physician & pharmacist improve outcomes? 👀 @fperrywilson thread for a presentation breakdown!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
1
23
@Nephronette
Abinet Aklilu
9 months
RT @fperrywilson: Thrilled and very proud of @Nephronette who will be presenting the results of the Kidney Action Team Trial at #kidneywk i….
0
10
0
@Nephronette
Abinet Aklilu
10 months
RT @YaleNephrology: PPI use is a/w a slight ⬆️ CKD risk, but the nature of this risk remains uncertain & unexplained. We clearly need more….
Tweet card summary image
journals.lww.com
An abstract is unavailable.
0
4
0
@Nephronette
Abinet Aklilu
10 months
RT @ASNKidney360: The field of Onco-Nephrology has expanded to become a subspecialty within Nephrology. This series, led by Anushree Shiral….
0
13
0
@Nephronette
Abinet Aklilu
10 months
RT @SabineKaram6: Diversity, collegiality and excellence to be expected soon @ASNKidney @onconephsociety by @anushreeshirali and @Nephronet….
0
2
0